As of 2026-06-10, the EV/EBITDA ratio of Bafna Pharmaceuticals Ltd (BAFNAPH.NS) is 2.75. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BAFNAPH.NS's latest enterprise value is 3,471.50 mil INR. BAFNAPH.NS's TTM EBITDA according to its financial statements is 1,264.15 mil INR. Dividing these 2 quantities gives us the above BAFNAPH.NS EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 8.7x - 11.7x | 9.3x |
| Forward P/E multiples | 8.1x - 11.7x | 10.0x |
| Fair Price | 101.94 - 803.31 | 381.34 |
| Upside | -41.6% - 360.1% | 118.4% |
| Date | EV/EBITDA |
| 2026-06-09 | 2.75 |
| 2026-06-08 | 3.02 |
| 2026-06-05 | 2.77 |
| 2026-06-04 | 2.54 |
| 2026-06-03 | 2.43 |
| 2026-06-02 | 2.33 |
| 2026-06-01 | 2.23 |
| 2026-05-29 | 2.13 |
| 2026-05-27 | 2.11 |
| 2026-05-26 | 2.10 |
| 2026-05-25 | 2.19 |
| 2026-05-22 | 2.18 |
| 2026-05-21 | 2.20 |
| 2026-05-20 | 2.23 |
| 2026-05-19 | 2.19 |
| 2026-05-18 | 2.27 |
| 2026-05-15 | 2.19 |
| 2026-05-14 | 2.19 |
| 2026-05-13 | 2.23 |
| 2026-05-12 | 2.15 |
| 2026-05-11 | 2.18 |
| 2026-05-08 | 2.14 |
| 2026-05-07 | 2.13 |
| 2026-05-06 | 2.13 |
| 2026-05-05 | 2.17 |
| 2026-05-04 | 2.13 |
| 2026-04-30 | 2.17 |
| 2026-04-29 | 2.21 |
| 2026-04-28 | 2.15 |
| 2026-04-27 | 2.20 |
| 2026-04-24 | 2.20 |
| 2026-04-23 | 2.20 |
| 2026-04-22 | 2.16 |
| 2026-04-21 | 2.20 |
| 2026-04-20 | 2.24 |
| 2026-04-17 | 2.24 |
| 2026-04-16 | 2.17 |
| 2026-04-15 | 2.14 |
| 2026-04-13 | 2.17 |
| 2026-04-10 | 2.24 |
| 2026-04-09 | 2.20 |
| 2026-04-08 | 2.02 |
| 2026-04-07 | 1.88 |
| 2026-04-06 | 1.84 |
| 2026-04-02 | 1.88 |
| 2026-04-01 | 1.88 |
| 2026-03-30 | 1.86 |
| 2026-03-27 | 1.94 |
| 2026-03-25 | 1.92 |
| 2026-03-24 | 1.88 |